1. Home
  2. NLSP vs FDBC Comparison

NLSP vs FDBC Comparison

Compare NLSP & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • FDBC
  • Stock Information
  • Founded
  • NLSP 2015
  • FDBC 1902
  • Country
  • NLSP Switzerland
  • FDBC United States
  • Employees
  • NLSP N/A
  • FDBC N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • FDBC Major Banks
  • Sector
  • NLSP Health Care
  • FDBC Finance
  • Exchange
  • NLSP Nasdaq
  • FDBC Nasdaq
  • Market Cap
  • NLSP 5.2M
  • FDBC 307.8M
  • IPO Year
  • NLSP 2021
  • FDBC N/A
  • Fundamental
  • Price
  • NLSP $2.51
  • FDBC $48.03
  • Analyst Decision
  • NLSP
  • FDBC
  • Analyst Count
  • NLSP 0
  • FDBC 0
  • Target Price
  • NLSP N/A
  • FDBC N/A
  • AVG Volume (30 Days)
  • NLSP 531.5K
  • FDBC 9.2K
  • Earning Date
  • NLSP 01-07-2025
  • FDBC 01-22-2025
  • Dividend Yield
  • NLSP N/A
  • FDBC 3.29%
  • EPS Growth
  • NLSP N/A
  • FDBC N/A
  • EPS
  • NLSP N/A
  • FDBC 2.68
  • Revenue
  • NLSP N/A
  • FDBC $71,243,000.00
  • Revenue This Year
  • NLSP N/A
  • FDBC N/A
  • Revenue Next Year
  • NLSP N/A
  • FDBC N/A
  • P/E Ratio
  • NLSP N/A
  • FDBC $18.19
  • Revenue Growth
  • NLSP N/A
  • FDBC N/A
  • 52 Week Low
  • NLSP $1.73
  • FDBC $41.10
  • 52 Week High
  • NLSP $24.32
  • FDBC $61.21
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 52.44
  • FDBC 35.99
  • Support Level
  • NLSP $1.81
  • FDBC $47.70
  • Resistance Level
  • NLSP $2.79
  • FDBC $52.29
  • Average True Range (ATR)
  • NLSP 0.28
  • FDBC 1.45
  • MACD
  • NLSP 0.09
  • FDBC -0.47
  • Stochastic Oscillator
  • NLSP 74.72
  • FDBC 13.21

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About FDBC Fidelity D & D Bancorp Inc.

Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers.

Share on Social Networks: